Long-term Injectable Antipsychotic Cuts Schizophrenia RelapseLong-term Injectable Antipsychotic Cuts Schizophrenia Relapse

The long-term formulation of paliperidone, which is currently under FDA review, may be the first atypical antipsychotic administered on a four-times-a-year dosing schedule. Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Source Type: news